Gene · 56477
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study. | Sci Rep | 2023 | 37973887 | PubTator, text mining | PubMed |
| Structural Insight into Polymerase Mechanism via a Chiral Center Generated with a Single Selenium Atom. | Int J Mol Sci | 2023 | 37958741 | PubTator, text mining | PubMed |
| DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. | Cancers (Basel) | 2023 | 37958405 | PubTator, text mining | PubMed |
| Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2023 | 37958391 | PubTator, text mining | PubMed |
| Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. | Front Immunol | 2023 | 37954590 | PubTator, text mining | PubMed |
| Bone Marrow-Derived GCA+ Immune Cells Drive Alzheimer's Disease Progression. | Adv Sci (Weinh) | 2023 | 37949676 | PubTator, text mining | PubMed |
| Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens. | Vaccines (Basel) | 2023 | 37896988 | PubTator, text mining | PubMed |
| Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics. | Cancers (Basel) | 2023 | 37894443 | PubTator, text mining | PubMed |
| The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation. | Biomedicines | 2023 | 37893029 | PubTator, text mining | PubMed |
| Panton-Valentine Leukocidin (PVL) genes may not be a reliable marker for community-acquired MRSA in the Dakahlia Governorate, Egypt. | BMC Microbiol | 2023 | 37891473 | PubTator, text mining | PubMed |
| Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway. | Cancer Cell Int | 2023 | 37884956 | PubTator, text mining | PubMed |
| Active Ising Models of flocking: a field-theoretic approach. | Eur Phys J E Soft Matter | 2023 | 37882912 | PubTator, text mining | PubMed |
| Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature. | Sci Rep | 2023 | 37875556 | PubTator, text mining | PubMed |
| A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's Disease. | bioRxiv | 2023 | 37873404 | PubTator, text mining | PubMed |
| NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype. | Cell Commun Signal | 2023 | 37853467 | PubTator, text mining | PubMed |
| The strategies to cure cancer patients by eradicating cancer stem-like cells. | Mol Cancer | 2023 | 37853413 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker. | Eur J Med Res | 2023 | 37848933 | PubTator, text mining | PubMed |
| An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche. | Development | 2023 | 37840454 | PubTator, text mining | PubMed |
| Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial. | Nutrients | 2023 | 37836458 | PubTator, text mining | PubMed |
| Keras/TensorFlow in Drug Design for Immunity Disorders. | Int J Mol Sci | 2023 | 37834457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56477/papers?page=10